FRANKFURT, Dec 19 (Reuters) – Fresenius now
expects its planned takeover of Akorn, a U.S. maker of
liquid generic drugs, to be completed in early 2018 rather than
this year, a spokesman for Fresenius said on Tuesday.

Read More At Article Source | Article Attribution